🇺🇸 FDA
Patent

US 9346866

Inhibition of tace activity with cyclic peptides

granted A61KA61K38/10A61K38/12

Quick answer

US patent 9346866 (Inhibition of tace activity with cyclic peptides) held by The Regents of the University of California expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/10, A61K38/12, A61K38/1729, A61K38/55